Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study

Journal of Internal Medicine, 04/26/2012

The results of this study support the findings from the prelicensure clinical trials, providing reassurance that the zoster vaccine is generally safe and well–tolerated with a small increased risk of allergic reactions in 1–7 days after vaccination.

Print Article Summary